2.07
前日終値:
$2.10
開ける:
$2.13
24時間の取引高:
115.97K
Relative Volume:
0.24
時価総額:
$130.88M
収益:
$4.39M
当期純損益:
$-22.40M
株価収益率:
-4.0604
EPS:
-0.5098
ネットキャッシュフロー:
$-22.79M
1週間 パフォーマンス:
+0.98%
1か月 パフォーマンス:
+5.08%
6か月 パフォーマンス:
+64.29%
1年 パフォーマンス:
+417.24%
Equillium Inc Stock (EQ) Company Profile
Compare EQ vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
EQ
Equillium Inc
|
2.07 | 132.78M | 4.39M | -22.40M | -22.79M | -0.5098 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-23 | 開始されました | Oppenheimer | Outperform |
| 2026-04-16 | 開始されました | B. Riley Securities | Buy |
| 2026-04-14 | 開始されました | Raymond James | Strong Buy |
| 2026-04-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2026-03-13 | 開始されました | Roth Capital | Buy |
| 2026-02-25 | 開始されました | Stifel | Buy |
| 2025-03-28 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2021-10-29 | 再開されました | Stifel | Buy |
| 2021-09-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-07-14 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-10 | 再開されました | Stifel | Buy |
| 2019-02-22 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Equillium Inc (EQ) 最新ニュース
Should you add Equillium (EQ) to your watchlist today? (Bearish Momentum) 2026-05-05Overbought Alert - Newser
Equillium, Inc. Grants Inducement Stock Options to New Employees Under 2024 Inducement Plan - Quiver Quantitative
Two new Equillium hires receive options for 800,000 shares - Stock Titan
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Weekly Voice
EQ Stock Price, Quote & Chart | EQUILLIUM INC (NASDAQ:EQ) - ChartMill
B Riley Securities initiates coverage of Equillium (EQ) with buy recommendation - MSN
Equillium (EQ) price target increased by 120.00% to 5.61 - MSN
Oppenheimer Initiates Equillium(EQ.US) With Buy Rating, Announces Target Price $7 - Moomoo
Equillium (NASDAQ:EQ) Coverage Initiated by Analysts at Oppenheimer - MarketBeat
Oppenheimer Initiates Coverage on Equillium With Outperform Rating, $7 Price Target - marketscreener.com
Oppenheimer initiates Equillium stock with Outperform on UC drug By Investing.com - Investing.com Australia
Oppenheimer initiates Equillium stock with Outperform on UC drug - Investing.com
Equillium initiated with an Outperform at Oppenheimer - TipRanks
Is It Stable or Volatile | Equillium Inc. Posts 35.3% EPS Beat, Narrower Net Loss Vs EstimatesElite Trading Signals - Cổng thông tin điện tử tỉnh Lào Cai
Roth MKM Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event - The Manila Times
EQ Reiterated by Roth Capital -- Price Target Maintained at $12 - GuruFocus
Equillium (EQ) price target increased by 10.71% to 7.90 - MSN
Roth Mkm Reiterates Buy Rating for Equillium (NASDAQ:EQ) - MarketBeat
[EFFECT] Equillium, Inc. SEC Filing - Stock Titan
Here’s what Roth Capital thinks of Equillium (EQ) stock - MSN
EQ Upgraded by B. Riley Securities -- Price Target Announced at $6.00 - GuruFocus
B. Riley Securities Initiates Equillium(EQ.US) With Buy Rating, Announces Target Price $6 - Moomoo
Equillium (NASDAQ:EQ) Earns Buy Rating from Analysts at B. Riley Financial - MarketBeat
B. Riley Initiates Equillium at Buy With $6 Price Target - marketscreener.com
B.Riley initiates Equillium stock coverage with buy rating on UC drug By Investing.com - Investing.com South Africa
B.Riley initiates Equillium stock coverage with buy rating on UC drug - Investing.com
CapEx per share of Equillium, Inc. – FWB:0FY - TradingView
Equillium Inc : B. Riley Initiates Coverage W - Moomoo
Short Interest in Equillium, Inc. (NASDAQ:EQ) Grows By 36.6% - MarketBeat
[ARS] Equillium, Inc. SEC Filing - Stock Titan
Reverse split and share increase up for Equillium (NASDAQ: EQ) stockholder vote - Stock Titan
Equillium | DEF 14A: Definitive information statements - Moomoo
Equillium (EQ) price target increased by 27.27% to 7.14 - MSN
Raymond James Initiates Coverage of Equillium (EQ) with Strong Buy Recommendation - MSN
EQ Initiates Coverage On by Raymond James -- Strong Buy Rating A - GuruFocus
Raymond James Initiates Equillium at Strong Buy With $6 Price Target - Moomoo
EQ Initiates Coverage On by Raymond James -- Strong Buy Rating Announced - GuruFocus
Raymond James initiates Equillium stock coverage with strong buy By Investing.com - Investing.com Australia
Raymond James initiates Equillium stock coverage with strong buy - Investing.com
Equillium Inc (EQ) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):